Afficher la notice abrégée

dc.rights.licenseopenen_US
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorLEFEVRE ARBOGAST, Sophie
dc.contributor.authorCHAKER, J.
dc.contributor.authorMERCIER, F.
dc.contributor.authorBAROUKI, R.
dc.contributor.authorCOUMOUL, X.
dc.contributor.authorMILLER, G. W.
dc.contributor.authorDAVID, A.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorSAMIERI, Cecilia
dc.date.accessioned2024-08-21T08:59:52Z
dc.date.available2024-08-21T08:59:52Z
dc.date.issued2024-05-01
dc.identifier.issn1546-1726en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/201216
dc.description.abstractEnOver the past few decades, numerous environmental chemicals from solvents to pesticides have been suggested to be involved in the development and progression of neurodegenerative diseases. Most of the evidence has accumulated from occupational or cohort studies in humans or laboratory research in animal models, with a range of chemicals being implicated. What has been missing is a systematic approach analogous to genome-wide association studies, which have identified dozens of genes involved in Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases. Fortunately, it is now possible to study hundreds to thousands of chemical features under the exposome framework. This Perspective explores how advances in mass spectrometry make it possible to generate exposomic data to complement genomic data and thereby better understand neurodegenerative diseases. Nongenetic factors contribute to the onset, progression and severity of neurodegenerative diseases. Here, the authors describe how exposomics, the systematic analysis of environmental factors, can help neuroscientists understand these diseases.
dc.language.isoENen_US
dc.rightsAttribution-NonCommercial 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/us/*
dc.title.enAssessing the contribution of the chemical exposome to neurodegenerative disease
dc.title.alternativeNat Neuroscien_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1038/s41593-024-01627-1en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed38684891en_US
bordeaux.journalNature Neuroscienceen_US
bordeaux.page812-821en_US
bordeaux.volume27en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.issue5en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamELEANOR_BPHen_US
bordeaux.teamLEHA_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.identifier.funderIDFondation de Franceen_US
bordeaux.identifier.funderIDFondation pour la Recherche Médicaleen_US
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exportfalse
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Nature%20Neuroscience&rft.date=2024-05-01&rft.volume=27&rft.issue=5&rft.spage=812-821&rft.epage=812-821&rft.eissn=1546-1726&rft.issn=1546-1726&rft.au=LEFEVRE%20ARBOGAST,%20Sophie&CHAKER,%20J.&MERCIER,%20F.&BAROUKI,%20R.&COUMOUL,%20X.&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée